Soma and Hypercalcaemia - a phase IV clinical study of FDA data

Summary:

Hypercalcaemia is reported as a side effect among people who take Soma (carisoprodol), especially for people who are female, 50-59 old, also take Dilaudid, and have Constipation.

The phase IV clinical study analyzes which people have Hypercalcaemia when taking Soma. It is created by eHealthMe based on reports of 15,632 people who have side effects when taking Soma from the FDA, and is updated regularly.

What is Soma?

Soma has active ingredients of carisoprodol. It is often used in muscle spasms. eHealthMe is studying from 17,137 Soma users. Check the latest studies of Soma.

What is Hypercalcaemia?

Hypercalcaemia (elevated calcium (ca+) level in the blood) is found to be associated with 1,064 drugs and 1,016 conditions by eHealthMe. Check the latest studies of Hypercalcaemia.

On Jul, 10, 2026

15,632 people reported to have side effects when taking Soma.
Among them, 29 people (0.19%) have Hypercalcaemia.

Among these 29 people:

What is the gender of people who have Hypercalcaemia when taking Soma? *

female: 70.37 %
male: 29.63 %

What is the age of people who have Hypercalcaemia when taking Soma? *

What are other drugs people take besides Soma? *

What are other side effects people have besides Hypercalcaemia? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 24 people, 82.76%
Oedema Peripheral (superficial swelling): 21 people, 72.41%
Stress And Anxiety: 20 people, 68.97%
Fall: 20 people, 68.97%
Dyspnea (difficult or laboured breathing): 19 people, 65.52%
Rib Fracture: 19 people, 65.52%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 19 people, 65.52%
Infection: 18 people, 62.07%
Injury: 18 people, 62.07%
Osteonecrosis Of Jaw (death of bone of jaw): 18 people, 62.07%

What are the existing conditions these people have? *

Breast Cancer: 10 people, 34.48%
Metastases To Bone (cancer spreads to bone): 10 people, 34.48%
Breast Cancer Metastatic: 10 people, 34.48%
Constipation: 10 people, 34.48%
Osteopenia (a condition where bone mineral density is lower than normal): 4 people, 13.79%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.90%
Urinary Tract Disorder: 1 person, 3.45%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.45%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 3.45%
Depression: 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Soma and have Hypercalcaemia?

- Check whether Hypercalcaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Soma:

Soma (17,137 reports)

Hypercalcaemia treatments and more:

Hypercalcaemia (18,731 reports)

Browse all side effects of Soma:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercalcaemia:

Hypercalcaemia (1,064 drugs)

Browse all the conditions that are associated with Hypercalcaemia:

Hypercalcaemia (1,016 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carisoprodol (the active ingredients of Soma) and Soma (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.